Reductive Bioactivation

Reductive Bioactivation is a type of metabolic activation process in which a biologically inert compound is converted into an active pharmacological agent through reductive reactions mediated by enzymatic or chemical reduction within biological systems.

35

Publications

1.8K

Citations

135

Authors

55

Institutions

Publications per year

2017–2026

2

Publications

35

Authors

135

  1. MI
    Michael I. Walton

    Institute of Cancer Research, United Kingdom

    4 publications · 341 citations

    4

    h-index

  2. PW
    Paul Workman

    Institute of Cancer Research, United Kingdom

    4 publications · 341 citations

    4

    h-index

  3. NV
    Nico Vermeulen

    Vrije Universiteit Amsterdam, Netherlands

    3 publications · 124 citations

    3

    h-index

  4. CR
    C. Roland Wolf

    Ninewells Hospital, United Kingdom

    3 publications · 259 citations

    3

    h-index

  5. AR
    Arnold R. Goeptar

    Society of Environmental Toxicology and Chemistry, United States

    3 publications · 124 citations

    3

    h-index

1–5 of 135

Venues

  1. PubMed

    Repository · 6 publications · 312 citations

    6

    h-index

  2. Chemical Research in Toxicology

    5 publications · 138 citations

    5

    h-index

  3. Drug Metabolism and Disposition

    3 publications · 174 citations

    3

    h-index

  4. Biochemical Pharmacology

    3 publications · 177 citations

    3

    h-index

  5. Proceedings of the National Academy of Sciences

    PNAS · 2 publications · 382 citations

    2

    h-index

1–5